Davide Carlei

1.0k total citations
14 papers, 754 citations indexed

About

Davide Carlei is a scholar working on Oncology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Davide Carlei has authored 14 papers receiving a total of 754 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Immunology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Davide Carlei's work include Viral-associated cancers and disorders (6 papers), Virus-based gene therapy research (3 papers) and Immunotherapy and Immune Responses (3 papers). Davide Carlei is often cited by papers focused on Viral-associated cancers and disorders (6 papers), Virus-based gene therapy research (3 papers) and Immunotherapy and Immune Responses (3 papers). Davide Carlei collaborates with scholars based in Italy, Germany and United States. Davide Carlei's co-authors include Filippo Belardelli, Barbara Ensoli, Cecilia Sgadari, Elena Toschi, Sara Baccarini, Clelia Palladino, Paolo Monini, Giovanni Barillari, Ilaria Bacigalupo and Claudia Mauri and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and The Journal of Immunology.

In The Last Decade

Davide Carlei

14 papers receiving 733 citations

Peers

Countries citing papers authored by Davide Carlei

Since Specialization

Citations

This map shows the geographic impact of Davide Carlei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davide Carlei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davide Carlei more than expected).

Fields of papers citing papers by Davide Carlei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davide Carlei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davide Carlei. The network helps show where Davide Carlei may publish in the future.

Co-authorship network of co-authors of Davide Carlei

This figure shows the co-authorship network connecting the top 25 collaborators of Davide Carlei. A scholar is included among the top collaborators of Davide Carlei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davide Carlei. Davide Carlei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Chimeric Antigen Receptor Immunotherapy for Solid Tumors: Choosing the Right Ingredients for the Perfect Recipe 2022 ·Cancers ·Luciano Castiello, Laura Santodonato, Mariarosaria Napolitano, Davide Carlei, (unknown), (unknown), Giuseppina D’Agostino, Eleonora Aricò	4
2	A good manufacturing practice method to ex vivo expand natural killer cells for clinical use. 2015 ·PubMed ·G Torelli, Carmela Rozera, Laura Santodonato, Nadia Peragine, Giuseppina D’Agostino, (unknown), Mariarosaria Napolitano, (unknown), Davide Carlei, (unknown), (unknown), Maria Gozzer, (unknown), G. Girelli, Anna Guarini, Filippo Belardelli, Robin Foà	28
3	Human immunodeficiency virus protease inhibitors reduce the growth of human tumors via a proteasome‐independent block of angiogenesis and matrix metalloproteinases 2010 ·International Journal of Cancer ·Elena Toschi, Cecilia Sgadari, (unknown), Ilaria Bacigalupo, Chiara Chiozzini, Davide Carlei, (unknown), Stefania Bellino, Roberto Bugarini, Mario Falchi, Clelia Palladino, Patrizia Leone, Giovanni Barillari, Paolo Monini, Barbara Ensoli	43
4	A single administration of lentiviral vectors expressing either full-length human immunodeficiency virus 1 (HIV-1)HXB2 Rev/Env or codon-optimized HIV-1JR-FL gp120 generates durable immune responses in mice 2006 ·Journal of General Virology ·Viviana Buffa, Donatella Negri, Pasqualina Leone, Roberta Bona, Martina Borghi, Ilaria Bacigalupo, Davide Carlei, Cecilia Sgadari, Barbara Ensoli, Andrea Cara	23
5	The use of HAART for biological tumour therapy. 2006 ·PubMed ·Paolo Monini, Elena Toschi, Cecilia Sgadari, Ilaria Bacigalupo, Clelia Palladino, Davide Carlei, Giovanni Barillari, Barbara Ensoli	7
6	Type I IFN Protects Permissive Macrophages from Legionella pneumophila Infection through an IFN-γ-Independent Pathway 2004 ·The Journal of Immunology ·Giovanna Schiavoni, Claudia Mauri, Davide Carlei, Filippo Belardelli, Maddalena Castellani Pastoris, Enrico Proietti	59
7	Treatment of Kaposiʼs sarcoma—an update 2002 ·Anti-Cancer Drugs ·Elena Toschi, Cecilia Sgadari, Paolo Monini, Giovanni Barillari, Ilaria Bacigalupo, Clelia Palladino, Sara Baccarini, Davide Carlei, (unknown), Maria Caterina Sirianni, Barbara Ensoli	19
8	HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma 2002 ·Nature Medicine ·Cecilia Sgadari, Giovanni Barillari, Elena Toschi, Davide Carlei, Ilaria Bacigalupo, Sara Baccarini, Clelia Palladino, Patrizia Leone, Roberto Bugarini, (unknown), Aurelio Cafaro, Mario Falchi, Donatella Valdembri, Giovanni Rezza, Federico Bussolino, Paolo Monini, Barbara Ensoli	246
9	Activation of Matrix-Metalloproteinase-2 and Membrane-Type-1-Matrix-Metalloproteinase in Endothelial Cells and Induction of Vascular Permeability In Vivo by Human Immunodeficiency Virus-1 Tat Protein and Basic Fibroblast Growth Factor 2001 ·Molecular Biology of the Cell ·Elena Toschi, Giovanni Barillari, Cecilia Sgadari, Ilaria Bacigalupo, Anna Cereseto, Davide Carlei, Clelia Palladino, Christian Zietz, Patrizia Leone, Michael Stürzl, Stefano Buttò, Aurelio Cafaro, Paolo Monini, Barbara Ensoli	78
10	Mechanism of Paclitaxel Activity in Kaposi’s Sarcoma 2000 ·The Journal of Immunology ·Cecilia Sgadari, Elena Toschi, Clelia Palladino, Giovanni Barillari, Davide Carlei, Anna Cereseto, (unknown), Robert Yarchoan, Paolo Monini, Michael Stürzl, Barbara Ensoli	65
11	Interferon (IFN)-β Gene Transfer into TS/A Adenocarcinoma Cells and Comparison with IFN-α 1999 ·American Journal Of Pathology ·Carmela Rozera, Davide Carlei, Pier‐Luigi Lollini, Carla De Giovanni, Piero Musiani, Emma Di Carlo, Filippo Belardelli, Maria Ferrantini	38
12	Mechanism(s) of Paclitaxel Activity in Kaposi's Sarcoma (KS) 1999 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·(unknown), Elena Toschi, Clelia Palladino, Giovanni Barillari, (unknown), Davide Carlei, (unknown), Robert Yarchoan, Michael Stürzl, (unknown)	2
13	Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice. 1998 ·Journal of Clinical Investigation ·Enrico Proietti, Giampaolo Greco, (unknown), Sara Baccarini, Claudia Mauri, Massimo Venditti, Davide Carlei, Filippo Belardelli	123
14	Local and systemic antitumor response after combined therapy of mouse metastatic tumors with tumor cells expressing IFN-α and HSVtk: perspectives for the generation of cancer vaccines 1997 ·Gene Therapy ·Laura Santodonato, Giuseppina D’Agostino, Stefano M. Santini, Davide Carlei, Piero Musiani, Andrea Modesti, Paola Signorelli, Filippo Belardelli, Maria Ferrantini	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact